triamterene NDC 66993-831

NDC codes

FDA NDC Directory

Product NDC (as listed)66993-831Labeler and product segments. Claims need a package NDC.

Product NDC at billing width66993-0831Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
66993-831-02	66993083102	100 CAPSULE in 1 BOTTLE (66993-831-02)Marketed from Aug 13, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): triamterene
Generic name (nonproprietary): triamterene
Active ingredients: Triamterene — 50 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Prasco Laboratories
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 013174
Marketing start: Aug 13, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Renal K+ Excretion (Physiologic effect)Increased Diuresis (Physiologic effect)
Identifiers: Product ID 66993-831_d7ce0a55-ba61-4995-8141-43c4736d4be9SPL ID d7ce0a55-ba61-4995-8141-43c4736d4be9SPL set ID a09c2212-1dd5-4fbe-ad09-2a57aeabcaeaRxCUI 198312, 198313UNII WS821Z52LQUPC 0366993831022
Pharmacologic class: Potassium-sparing Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N466993083102 followed by a unit qualifier and the quantity

Package 66993-0831-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 3, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Triamterene capsules are indicated in the treatment of edema associated with congestive heart failure, cirrhosis of the liver and the nephrotic syndrome; steroid-induced edema, idiopathic edema and edema due to secondary hyperaldosteronism. Triamterene capsules may be used alone or with other diuretics, either for its added diuretic effect or its potassium-sparing potential. It also promotes increased diuresis when patients prove resistant or only partially responsive to thiazides or other diuretics because of secondary hyperaldosteronism. Usage in Pregnancy . The routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unn…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 013174

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 013174
Product	Strength	Form · route	Labeler	Product NDC
Triamterene	Triamterene 100 mg/1	CapsuleOral	Prasco Laboratories	66993-832
Dyreniumtriamterene	Triamterene 50 mg/1	CapsuleOral	Advanz Pharma (US) Corp.	59212-002
Dyreniumtriamterene	Triamterene 100 mg/1	CapsuleOral	Advanz Pharma (US) Corp.	59212-003